Multiple Sclerosis Information
View Article  Autoinjection Device Appears subcutaneous injections of interferon beta (IFNB)-1a
A new electronic, multidose, autoinjection device improves subcutaneous delivery of interferon beta (IFNB)-1a in patients with relapsing multiple sclerosis (MS), according to a study presented here at the 19th Meeting of the European   more »
View Article  Mitoxandrone - Leukemia Risk
Patients with multiple sclerosis who are treated with a cumulative dose of 82 mg/m[2 of Mitoxandrone (MTX) are at a 2.7 higher risk of developing acute leukemia (AL), according to a late-breaking abstract presented on April 30   more »